{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:58:15Z","timestamp":1789203495430,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.pcad.2006.03.001","type":"journal-article","created":{"date-parts":[[2006,7,25]],"date-time":"2006-07-25T07:55:11Z","timestamp":1153814111000},"page":"1-10","source":"Crossref","is-referenced-by-count":33,"title":["Progress in Cardiovascular Diseases"],"prefix":"10.1016","volume":"49","author":[{"given":"Willem H.","family":"Birkenh\u00e4ger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Staessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2006.03.001_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(96)09328-2","article-title":"Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study","volume":"349","author":"Hofman","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2006.03.001_bib2","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(04)15900-X","article-title":"Convergence of atherosclerosis and Alzheimer's disease: Inflammation, cholesterol, and misfolded proteins","volume":"363","author":"Casserly","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2006.03.001_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(00)03589-3","article-title":"Pathological correlation of late-onset dementia in a multicentre, community-based population in England and Wales","volume":"357","author":"Neuropathology Group Medical Research Council Cognitive Function and Aging Study","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2006.03.001_bib4","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1192\/bjp.167.5.642","article-title":"A prevalence study of age-associated memory impairment","volume":"167","author":"Barker","year":"1995","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pcad.2006.03.001_bib5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp.56.9.973","article-title":"Prevalence of age-associated memory impairment and dementia in a rural community","volume":"56","author":"Coria","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pcad.2006.03.001_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/S1041610294001663","article-title":"Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function","volume":"6","author":"Larrabee","year":"1994","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.pcad.2006.03.001_bib7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.40.4.626","article-title":"Prevalence of clinically diagnosed Alzheimer's disease and other dementing disorders: A door-to-door survey in Appigano macerata Province, Italy","volume":"40","author":"Rocca","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.pcad.2006.03.001_bib8","first-page":"899","article-title":"Canadian Study of Health and Aging: Study methods and prevalence of dementia","volume":"150","year":"1994","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.pcad.2006.03.001_bib9","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2105\/AJPH.84.8.1261","article-title":"The US economic and social costs of Alzheimer's disease revisited","volume":"84","author":"Ernst","year":"1994","journal-title":"Am J Public Health"},{"key":"10.1016\/j.pcad.2006.03.001_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00002512-199915050-00004","article-title":"Worldwide prevalence and incidence of dementia","volume":"15","author":"Fratiglioni","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.pcad.2006.03.001_bib11","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2105\/AJPH.88.9.1337","article-title":"Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset","volume":"88","author":"Brookmeyer","year":"1998","journal-title":"Am J Public Health"},{"key":"10.1016\/j.pcad.2006.03.001_bib12","first-page":"2005","article-title":"Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): Randomised double-blind trial","volume":"363","author":"Courtney","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2006.03.001_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.jhh.1001118","article-title":"Cerebral complications of hypertension","volume":"14","author":"Rigaud","year":"2000","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.pcad.2006.03.001_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/archinte.161.2.152","article-title":"Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension","volume":"161","author":"Birkenh\u00e4ger","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2006.03.001_bib15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM200008173430709","article-title":"Detection of preclinical Alzheimer's disease","volume":"343","author":"Skoog","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2006.03.001_bib16","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1073\/pnas.052587399","article-title":"Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered MRI","volume":"99","author":"Scahill","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pcad.2006.03.001_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/oxfordjournals.aje.a116868","article-title":"Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study","volume":"138","author":"Elias","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pcad.2006.03.001_bib18","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","article-title":"A 15-year longitudinal study of blood pressure and dementia","volume":"347","author":"Skoog","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2006.03.001_bib19","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.HYP.31.3.780","article-title":"Hypertension is related to cognitive impairment: A 20-year follow-up study of 999 men","volume":"31","author":"Kilander","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2006.03.001_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0197-4580(00)00096-8","article-title":"Midlife blood pressure and dementia: The Honolulu-Asia aging study","volume":"21","author":"Launer","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pcad.2006.03.001_bib21","series-title":"Assessment of hypertensive organ damage","first-page":"303","article-title":"Blood pressure and dementia","volume":"vol. 18","author":"Skoog","year":"1997"},{"key":"10.1016\/j.pcad.2006.03.001_bib22","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.STR.0000014421.15948.67","article-title":"Alzheimer disease as a vascular disorder: Nosological evidence","volume":"33","author":"De la Torre","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.pcad.2006.03.001_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/01.HYP.0000145858.07252.99","article-title":"Blood-pressure related cognitive decline: Does age make a difference?","volume":"44","author":"Elias","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2006.03.001_bib24","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2006.03.001_bib25","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/S0140-6736(03)13616-1","article-title":"Progression of cerebral white matter lesions: 6-year results of the Austrian stroke prevention study","volume":"361","author":"Schmidt","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2006.03.001_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000070183","article-title":"Validation study of a CT-based weighted rating scale for subcortical ischemic vascular disease in patients with mild cognitive deterioration","volume":"49","author":"Geroldi","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1016\/j.pcad.2006.03.001_bib27","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1212\/WNL.56.7.921","article-title":"Longitudinal study of blood pressure and white matter hyperintensities. The EVA MRI cohort","volume":"56","author":"Dufouil","year":"2001","journal-title":"Neurolgy"},{"key":"10.1016\/j.pcad.2006.03.001_bib28","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/awf077","article-title":"Hypertension and cerebral white matter lesions in a prospective cohort study","volume":"125","author":"De Leeuw","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.pcad.2006.03.001_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.HYP.0000145857.98904.20","article-title":"The association between blood pressure, hypertension and cerebral white matter lesions: The CASCADE study","volume":"44","author":"Van Dijk","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2006.03.001_bib30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(99)07330-4","article-title":"Risks of untreated and treated isolated systolic hypertension in the elderly","volume":"355","author":"Staessen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2006.03.001_bib31","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archneur.56.8.991","article-title":"Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use","volume":"56","author":"Guo","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pcad.2006.03.001_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneur.60.2.223","article-title":"Low blood pressure and risk of dementia in the Kungsholmen project: A 6-year follow-up study","volume":"60","author":"Qiu","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pcad.2006.03.001_bib33","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1212\/WNL.53.9.1948","article-title":"Cognitive decline in individuals with high blood pressure","volume":"53","author":"Tzourio","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pcad.2006.03.001_bib34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/bmj.312.7034.801","article-title":"Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults","volume":"312","author":"Prince","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.pcad.2006.03.001_bib35","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jama.281.5.438","article-title":"Current and remote blood pressure and cognitive decline","volume":"281","author":"Glynn","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2006.03.001_bib36","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.56.12.1683","article-title":"Midlife vascular risk factors and late-midlife cognitive impairment: A population study","volume":"56","author":"Kipivelto","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pcad.2006.03.001_bib37","first-page":"818","article-title":"Blood pressure and cognitive functioning among independent elderly","volume":"16","author":"Paran","year":"2003","journal-title":"AJH"},{"key":"10.1016\/j.pcad.2006.03.001_bib38","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1001\/archinte.162.18.2090","article-title":"Preservation of cognitive function with antihypertensive medications: A longitudinal analysis of a community-based sample of African Americans","volume":"162","author":"Murray","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2006.03.001_bib39","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1001\/archinte.1994.00420190047006","article-title":"Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program","volume":"154","author":"Applegate","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2006.03.001_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/aje\/153.1.72","article-title":"Dementia and disability outcomes in large hypertension trials: Lessons learned from the Systolic Hypertension in the Elderly Program (SHEP) trial","volume":"153","author":"DiBari","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pcad.2006.03.001_bib41","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cardiovascular disease","volume":"163","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2006.03.001_bib42","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The Study on Cognition and Prognosis in the Elderly (SCOPE): Principal results of a randomized double-blind intervention trial","volume":"21","author":"Lithell","year":"2003","journal-title":"J. Hypertens"},{"key":"10.1016\/j.pcad.2006.03.001_bib43","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial","volume":"352","author":"Forette","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2006.03.001_bib44","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00004872-200404000-00029","article-title":"Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial","volume":"22","author":"Staessen","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2006.03.001_bib45","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe (Syst-Eur) Study","volume":"162","author":"Forette","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2006.03.001_bib46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.scds.2003.00.025","article-title":"Antihypertensive treatment and prevention of stroke and dementia","volume":"3","author":"Wang","year":"2003","journal-title":"Semin in Cerebrovasc Dis Stroke"},{"key":"10.1016\/j.pcad.2006.03.001_bib47","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1532-5415.1997.tb03191.x","article-title":"The association of antihypertensive agents with MRI white matter findings and with modified Mini-Mental State Examinations in older adults","volume":"45","author":"Heckbert","year":"1997","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.pcad.2006.03.001_bib48","first-page":"501","article-title":"Calcium channel blockers and cognitive function in elderly people: Results from the Canadian Study of Health and Aging","volume":"161","author":"Maxwell","year":"1999","journal-title":"CMAJ"},{"key":"10.1016\/j.pcad.2006.03.001_bib49","doi-asserted-by":"crossref","first-page":"26A","DOI":"10.1016\/S0895-7061(99)80085-5","article-title":"Evidence of confounding by indications: Prescribing of calcium antagonists","volume":"12","author":"Leader","year":"1999","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2006.03.001_bib50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00044011-199611040-00001","article-title":"Nimodipine in the treatment of probable Alzheimer's disease. Results of two multicenter trials","volume":"11","author":"Morich","year":"1996","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.pcad.2006.03.001_bib51","article-title":"Calcium channel blockers and the risk of AD: The Baltimore Longitudinal Study of Aging","author":"Jasar","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pcad.2006.03.001_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1989.tb12485.x","article-title":"Calcium, membranes, aging","volume":"568","author":"Khachaturian","year":"1989","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pcad.2006.03.001_bib53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0143-4160(98)90064-1","article-title":"Calcium dysregulation in neuronal aging and Alzheimer's disease: History and new directions","volume":"25","author":"Thibault","year":"1998","journal-title":"Ceeel Calcium"},{"key":"10.1016\/j.pcad.2006.03.001_bib54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/phrs.1998.0411","article-title":"Calcium alterations in Alzheimer's disease: Pathophysiology, models, and therapeutic opportunities","volume":"39","author":"Pascale","year":"1999","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pcad.2006.03.001_bib55","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrn960","article-title":"Calcium dyshomeostasis and intracellular signaling in Alzheimer's disease","volume":"3","author":"LaPerla","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pcad.2006.03.001_bib56","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJM199911113412011","article-title":"Reducing calcium overload in the ischemic brain","volume":"341","author":"Zipfel","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2006.03.001_bib57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0006-8993(85)90680-8","article-title":"Autoradiographic localization of calcium channel antagonist receptors in rat brain with [3H] nitrendipine","volume":"330","author":"Gould","year":"1985","journal-title":"Brain Res"},{"issue":"Suppl 3","key":"10.1016\/j.pcad.2006.03.001_bib58","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/00004872-199610003-00006","article-title":"Vascular and neuronal brain damage: Protective effect of treatment with nicardipine","author":"Amenta","year":"1996","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2006.03.001_bib59","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00041552-200403000-00011","article-title":"Dementia and antihypertensive treatment","volume":"13","author":"Birkenh\u00e4ger","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.pcad.2006.03.001_bib60","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. The Anti-hypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2006.03.001_bib61","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol, adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial","volume":"366","author":"Dahl\u00f6f","year":"2005","journal-title":"Lancet"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062006000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062006000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T03:20:41Z","timestamp":1555730441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062006000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0033062006000259"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2006.03.001","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}